Lexeo Therapeutics to Host PKP2-ACM Clinical Endpoints Event
Lexeo Therapeutics announced it will host an educational investor event focused on clinical endpoints and outcome measures in PKP2-ACM.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lexeo Therapeutics to host educational event on PKP2-ACM clinical endpoints
The company will host an educational event focused on clinical endpoints and outcome measures in PKP2-ACM.